Target intelligence / Profile preview

Branched-chain alpha-ketoacid dehydrogenase complex E1 (BCKDH E1)

Target
BCKDH E1
Molecular classification
Enzyme, Oxidoreductase, Multienzyme complex component
01

Overview

The Branched-chain alpha-ketoacid dehydrogenase complex E1 (BCKDH E1) is the rate-limiting enzyme component of the mitochondrial BCKDH multienzyme complex [1, 2]. It catalyzes the oxidative decarboxylation of branched-chain alpha-keto acids (BCKAs) derived from the essential amino acids leucine, isoleucine, and valine [3]. The E1 component is a heterotetramer composed of two alpha (BCKDHA) and two beta (BCKDHB) subunits and requires thiamine pyrophosphate (TPP) as a vital cofactor [1, 2]. Genetic mutations in the E1 subunits lead to Maple Syrup Urine Disease (MSUD), a condition characterized by the toxic accumulation of branched-chain amino acids (BCAAs) and their ketoacid derivatives, which can cause severe neurological damage [3]. In addition to its role in rare genetic disorders, BCKDH activity is increasingly recognized as a factor in metabolic health, where its suppression is linked to insulin resistance, obesity, and heart failure [5]. Therapeutic strategies include high-dose thiamine for responsive MSUD variants and the use of kinase inhibitors like phenylbutyrate to maintain the complex in its active, dephosphorylated state [4]. Sources: [1] UniProt Consortium. P12694 (BCKDHA). [2] UniProt Consortium. P21953 (BCKDHB). [3] StatPearls. Maple Syrup Urine Disease. [4] Brunetti-Pierri N, et al. (2011). Phenylbutyrate therapy for maple syrup urine disease. Human Molecular Genetics. [5] Tso SC, et al. (2014). Structural Basis for the Allosteric Inhibition of the BCKDH Kinase by a Novel Small Molecule. Journal of Biological Chemistry.

Other names
2-oxoisovalerate dehydrogenase (lipoamide)Branched-chain alpha-keto acid dehydrogenaseBCKADBCKDHAlpha-ketoacid dehydrogenase
02

Mechanism of action

Cofactor supplementation (Thiamine) to enhance enzyme activity in responsive mutations; inhibition of branched-chain alpha-ketoacid dehydrogenase kinase (BCKDK) by drugs like phenylbutyrate to prevent the phosphorylation-mediated inactivation of the E1 subunit, thereby increasing overall complex activity.

03

Biological functions

Branched-chain amino acid catabolismOxidative decarboxylationEnergy metabolismTricarboxylic acid cycle precursor production
04

Disease associations

Maple Syrup Urine DiseaseType 2 diabetesObesityHeart failureMaple syrup urine disease, type 1AMaple syrup urine disease, type 1B
05

Safety considerations

Neurotoxicity from metabolite accumulationMetabolic acidosisPotential for excessive BCAA depletion leading to protein deficiencyRisk of cerebral edema in acute MSUD decompensation
06

Interacting drugs

Thiamine

2 more in the full profile.

07

Biomarkers

LeucineIsoleucineValineAlloisoleucineBranched-chain alpha-keto acids (BCKA)

Beyond the preview

Go deeper on Branched-chain alpha-ketoacid dehydrogenase complex E1 (BCKDH E1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Branched-chain alpha-ketoacid dehydrogenase complex E1 (BCKDH E1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call